US 2022/0023247 A1Published application

Pharmaceutical compositions and pharmacokinetics of a gamma-hydroxybutyric acid derivative

AssigneeXwpharma Ltd.

InventorsWILLIAM W. XIANG, JIA-NING XIANG, DANIEL M. CANAFAX

Life of this patent

Estimating the term…

Abstract

Pharmaceutical compositions of 4-((L-valyl)oxy)butanoic acid and the pharmacokinetics of 4-((L-valyl)oxy)butanoic acid and γ-hydroxybutyric acid following oral administration of the pharmaceutical compositions to healthy subjects are disclosed.

Claims20

Dependent claims

A pharmaceutical composition comprising an aqueous solution comprising 4-((L-valyl)oxy)butanoic acid (1) or a pharmaceutically acceptable salt thereof

Dependencies are inferred from the claim text.

Facts

Application: 17/383,253Filed 22 Jul 2021
Priority: 24 Jul 2020
Published: 27 Jan 2022
Term ends: Not estimatedThe source records don’t support an estimate.

Classification13 codes

A61K 31/223
Of acyclic acids, e.g. pravastatin: of alpha-aminoacids
A61K 9/0053
Galenical forms characterised by the site of application: mouth and digestive tract, i.e. intraoral and peroral administration
A61K 9/0095
Galenical forms not covered by A61K9/02 - A61K9/7023: drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets…
A61K 9/08
Medicinal preparations characterised by special physical form: solutions

Family

Application63/056,141Us provisional application · filed 24 Jul 2020
Application63/059,514Us provisional application · filed 31 Jul 2020
US 11,896,573 B2Related patent
US 2022/0023247 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results